FDA Drug Application (062645) for ULTRAGRIS-165 by PLIVA

Back to FDA Applications sponsored by PLIVA

Application Number062645
Product Number001
FormTABLET;ORAL
Dosage165MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameULTRAGRIS-165
Active IngredientGRISEOFULVIN, ULTRAMICROCRYSTALLINE



Back to FDA Applications sponsored by PLIVA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.